RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Philadelphia, PA · Pittsburgh, PA · +29 more sites
Prostate Cancer clinical trials in Philadelphia, PA
33 recruiting prostate cancer studies with a site in Philadelphia, PA.
RecruitingPhase 1NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Philadelphia, PA · +11 more sites
RecruitingNot applicableNCT06496256
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Sponsor: Palette Life Sciences, Inc.
Philadelphia, PA · +10 more sites
RecruitingPhase 1NCT05818683
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Philadelphia, PA · +6 more sites
RecruitingPhase not listedNCT07124000
DESTINY-PANTUMOUR04
Sponsor: AstraZeneca
Philadelphia, PA · +17 more sites
RecruitingPhase 1NCT07277270
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Philadelphia, PA · +4 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Philadelphia, PA · +34 more sites
RecruitingPhase 2NCT04038502
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Sponsor: VA Office of Research and Development
Philadelphia, PA · +17 more sites
RecruitingPhase 1NCT07493512
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Philadelphia, PA · Pittsburgh, PA · +10 more sites
RecruitingNot applicableNCT05804318
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Sponsor: Varian, a Siemens Healthineers Company
Philadelphia, PA · +4 more sites
RecruitingPhase 2NCT07111507
A Study of Tarlatamab for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Philadelphia, PA · +9 more sites
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
Philadelphia, PA · Pittsburgh, PA · +23 more sites
RecruitingPhase 2NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Sponsor: Prostate Cancer Clinical Trials Consortium
Philadelphia, PA · +7 more sites
RecruitingPhase 1 / Phase 2NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Sponsor: Novartis Pharmaceuticals
Philadelphia, PA · +21 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Altoona, PA · Beaver, PA · Broomall, PA · +338 more sites
RecruitingPhase 1NCT06966024
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Sponsor: Deciphera Pharmaceuticals, LLC
Philadelphia, PA · +7 more sites
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
Philadelphia, PA · +11 more sites
RecruitingPhase 3NCT07052214
PSMA PET Combined With MRI for the Detection of PCa
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Philadelphia, PA · +15 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Chadds Ford, PA · Danville, PA · Dickson City, PA · +371 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
Philadelphia, PA · +23 more sites
RecruitingPhase not listedNCT05242744
FTT PET/CT in Metastatic Prostate Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Philadelphia, PA
RecruitingPhase 1 / Phase 2NCT06457919
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Philadelphia, PA · +11 more sites
RecruitingPhase 2NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Sponsor: Sun Pharmaceutical Industries Limited
Philadelphia, PA · +11 more sites
RecruitingPhase 2 / Phase 3NCT04787744
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Sponsor: VA Office of Research and Development
Philadelphia, PA · +19 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Philadelphia, PA · +13 more sites
RecruitingPhase 1 / Phase 2NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Philadelphia, PA · +12 more sites
RecruitingNot applicableNCT07234968
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Sponsor: Thomas Jefferson University
Philadelphia, PA
RecruitingPhase 2NCT06591819
Hypofractionated WPPT With HDR Boost
Sponsor: Abramson Cancer Center at Penn Medicine
Philadelphia, PA
RecruitingPhase 4NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Sponsor: Guerbet
Hershey, PA · Philadelphia, PA · +14 more sites
RecruitingNot applicableNCT07219303
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
Sponsor: Fox Chase Cancer Center
Philadelphia, PA
Not yet recruitingPhase 3NCT06024772
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Sponsor: Thomas Jefferson University
Philadelphia, PA
Not yet recruitingPhase 2NCT07723651
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Sponsor: Washington University School of Medicine
Philadelphia, PA · +2 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Philadelphia, PA · Pittsburgh, PA · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.